Johnson & Johnson (JNJ) vs Palantir Technologies Inc. (PLTR)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Palantir Technologies is an artificial intelligence, data analytics, and automated decision-making company that helps organizations improve efficiency through data-driven operations. It serves commercial customers through its Foundry platform and government clients through Gotham. Palantir works exclusively with organizations in Western-allied nations and maintains the right to decline engagements it views as contrary to Western values. Founded in 2003, the company became publicly traded in 2020.